During the past decade, FinnMedi Oy conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 3 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "FinnMedi Oy" are "Cardiovascular Disease" (2 trials), "Atopic Dermatitis" (1 trials), "Hyperglycemia" (1 trials), "Insulin Resistance" (1 trials) and "Obesity" (1 trials). Many other conditions were trialed in "FinnMedi Oy" in a lesser frequency.

Most popular intervention types in "FinnMedi Oy" are "Drug" (4 trials), "Dietary Supplement" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "bococizumab (PF-04950615)" (2 trials), "Bifidobacterium animalis ssp. lactis 420" (1 trials), "Cis-UCA 2.5% emulsion cream" (1 trials) and "Cis-UCA 5% emulsion cream" (1 trials). Other intervention names were less common.

The vast majority of trials in "FinnMedi Oy" are 5 trials for "All" genders.

Currently, there are NaN active trials in "FinnMedi Oy". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in FinnMedi Oy, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in FinnMedi Oy, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".